ArticleMolecular microbiology2026
Bacterial Toxin Exploits Host Membrane Phospholipid as a Receptor for Binding, Entry, and Cytopathogenicity.
Article in Molecular microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Mycoplasma pneumoniae is a leading cause of bacterial community-acquired pneumonia, responsible for severe respiratory and extrapulmonary diseases in children and adults. The Community Acquired Respiratory Distress Syndrome (CARDS) toxin is a key virulence factor that exerts ADP-ribosylating and vacuolating activities on host cells, recapitulating the inflammatory and histopathological damage seen in infected airways. Although the host proteins annexin-A2 (AnxA2) and surfactant protein-A were previously identified as toxin receptors, their absence did not abrogate CARDS toxin activity. Intriguingly, our subsequent work identified an interaction between CARDS toxin and the ubiquitous membrane phospholipids sphingomyelin (SM) and phosphatidylcholine (PC). This study investigated whether CARDS toxin uses these lipids as functional cell surface receptors. Using enzyme-linked immunosorbent assays, we demonstrated that the carboxy region of CARDS toxin binds to SM and PC in a dose-dependent manner, exhibiting higher affinity for SM. Depletion of SM from airway epithelial cell surface significantly reduced CARDS toxin binding, internalization and retrograde transport, as shown by immunoblot, pull-down, immunofluorescence, and live-cell imaging. Furthermore, SM depletion markedly decreased toxin-induced vacuolation and its stability, a phenotype rescued by adding exogenous SM. Notably, combining SM depletion with AnxA2 suppression nearly abolished toxin binding, entry, and subsequent vacuolation. These findings establish that CARDS toxin utilizes SM as a functional receptor to mediate its activity, highlighting a critical lipid-dependent mechanism for host cell targeting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.